141 related articles for article (PubMed ID: 17532750)
1. Plasma concentrations of mycophenolic acid acyl glucuronide are not associated with diarrhea in renal transplant recipients.
Heller T; van Gelder T; Budde K; de Fijter JW; Kuypers D; Arns W; Schmidt J; Rostaing L; Powis SH; Claesson K; Macphee IA; Pohanka E; Engelmayer J; Brandhorst G; Oellerich M; Armstrong VW
Am J Transplant; 2007 Jul; 7(7):1822-31. PubMed ID: 17532750
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of mycophenolic acid and its glucuronide metabolites in stable adult liver transplant recipients with renal dysfunction on a low-dose calcineurin inhibitor regimen and mycophenolate mofetil.
Beckebaum S; Armstrong VW; Cicinnati VR; Streit F; Klein CG; Gerken G; Paul A; Oellerich M
Ther Drug Monit; 2009 Apr; 31(2):205-10. PubMed ID: 19307937
[TBL] [Abstract][Full Text] [Related]
3. AcylMPAG plasma concentrations and mycophenolic acid-related side effects in patients undergoing renal transplantation are not related to the UGT2B7-840G>A gene polymorphism.
van Agteren M; Armstrong VW; van Schaik RH; de Fijter H; Hartmann A; Zeier M; Budde K; Kuypers D; Pisarski P; Le Meur Y; van der Werf M; Mamelok RD; Oellerich M; van Gelder T
Ther Drug Monit; 2008 Aug; 30(4):439-44. PubMed ID: 18641546
[TBL] [Abstract][Full Text] [Related]
4. Chronopharmacokinetics of mycophenolic acid and its glucuronide and acyl glucuronide metabolites in kidney transplant recipients converted from cyclosporine to everolimus.
Tedesco-Silva H; Felipe CR; Slade A; Schmouder RL; Medina Pestana JO
Ther Drug Monit; 2012 Dec; 34(6):652-9. PubMed ID: 23131696
[TBL] [Abstract][Full Text] [Related]
5. Cyclosporine concentration-dependent increase in concentration ratio of mycophenolic acid acyl and phenol glucuronides to mycophenolic acid in stable kidney transplant recipients.
Mino Y; Naito T; Otsuka A; Ushiyama T; Ozono S; Kagawa Y; Kawakami J
Clin Biochem; 2009 May; 42(7-8):595-601. PubMed ID: 19100248
[TBL] [Abstract][Full Text] [Related]
6. Trough levels of mycophenolic acid and its glucuronidated metabolite in renal transplant recipients.
Merkel U; Lindner S; Vollandt R; Sperschneider H; Balogh A
Int J Clin Pharmacol Ther; 2005 Aug; 43(8):379-88. PubMed ID: 16119513
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of mycophenolic acid and its phenolic-glucuronide and ACYl glucuronide metabolites in stable thoracic transplant recipients.
Ting LS; Partovi N; Levy RD; Riggs KW; Ensom MH
Ther Drug Monit; 2008 Jun; 30(3):282-91. PubMed ID: 18520599
[TBL] [Abstract][Full Text] [Related]
8. Influence of renal insufficiency on pharmacokinetics of ACYL-glucuronide metabolite of mycophenolic acid in renal transplant patients.
González-Roncero FM; Govantes MA; Chaves VC; Palomo PP; Serra MB
Transplant Proc; 2007 Sep; 39(7):2176-8. PubMed ID: 17889129
[TBL] [Abstract][Full Text] [Related]
9. The occurrence of diarrhea not related to the pharmacokinetics of MPA and its metabolites in liver transplant patients.
Xia ZW; Jun CY; Hao C; Bing C; Min SM; Jie XJ
Eur J Clin Pharmacol; 2010 Jul; 66(7):671-9. PubMed ID: 20473489
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of mycophenolic acid and its glucuronidated metabolites in stable lung transplant recipients.
Ting LS; Partovi N; Levy RD; Riggs KW; Ensom MH
Ann Pharmacother; 2006 Sep; 40(9):1509-16. PubMed ID: 16882870
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic role of protein binding of mycophenolic acid and its glucuronide metabolite in renal transplant recipients.
de Winter BC; van Gelder T; Sombogaard F; Shaw LM; van Hest RM; Mathot RA
J Pharmacokinet Pharmacodyn; 2009 Dec; 36(6):541-64. PubMed ID: 19904584
[TBL] [Abstract][Full Text] [Related]
12. Investigation of the crossreactivity of mycophenolic acid glucuronide metabolites and of mycophenolate mofetil in the Cedia MPA assay.
Shipkova M; Schütz E; Besenthal I; Fraunberger P; Wieland E
Ther Drug Monit; 2010 Feb; 32(1):79-85. PubMed ID: 20042920
[TBL] [Abstract][Full Text] [Related]
13. Concentrations of mycophenolic acid and glucuronide metabolites under concomitant therapy with cyclosporine or tacrolimus.
Patel CG; Harmon M; Gohh RY; Akhlaghi F
Ther Drug Monit; 2007 Feb; 29(1):87-95. PubMed ID: 17304155
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and protein adduct formation of the pharmacologically active acyl glucuronide metabolite of mycophenolic acid in pediatric renal transplant recipients.
Shipkova M; Armstrong VW; Weber L; Niedmann PD; Wieland E; Haley J; Tönshoff B; Oellerich M;
Ther Drug Monit; 2002 Jun; 24(3):390-9. PubMed ID: 12021631
[TBL] [Abstract][Full Text] [Related]
15. Limited sampling models and Bayesian estimation for mycophenolic acid area under the curve prediction in stable renal transplant patients co-medicated with ciclosporin or sirolimus.
Musuamba FT; Rousseau A; Bosmans JL; Senessael JJ; Cumps J; Marquet P; Wallemacq P; Verbeeck RK
Clin Pharmacokinet; 2009; 48(11):745-58. PubMed ID: 19817503
[TBL] [Abstract][Full Text] [Related]
16. In vivo higher glucuronidation of mycophenolic acid in male than in female recipients of a cadaveric kidney allograft and under immunosuppressive therapy with mycophenolate mofetil.
Morissette P; Albert C; Busque S; St-Louis G; Vinet B
Ther Drug Monit; 2001 Oct; 23(5):520-5. PubMed ID: 11591897
[TBL] [Abstract][Full Text] [Related]
17. Comparison of mycophenolic acid pharmacokinetic parameters in kidney transplant patients within the first 3 months post-transplant.
Pawinski T; Durlik M; Szlaska I; Urbanowicz A; Majchrnak J; Gralak B
J Clin Pharm Ther; 2006 Feb; 31(1):27-34. PubMed ID: 16476117
[TBL] [Abstract][Full Text] [Related]
18. Unexpected augmentation of mycophenolic acid pharmacokinetics in renal transplant patients receiving tacrolimus and mycophenolate mofetil in combination therapy, and analogous in vitro findings.
Zucker K; Rosen A; Tsaroucha A; de Faria L; Roth D; Ciancio G; Esquenazi V; Burke G; Tzakis A; Miller J
Transpl Immunol; 1997 Sep; 5(3):225-32. PubMed ID: 9402690
[TBL] [Abstract][Full Text] [Related]
19. Mycophenolic acid metabolite profile in renal transplant patients receiving enteric-coated mycophenolate sodium or mycophenolate mofetil.
Tedesco-Silva H; Bastien MC; Choi L; Felipe C; Campestrini J; Picard F; Schmouder R
Transplant Proc; 2005 Mar; 37(2):852-5. PubMed ID: 15848554
[TBL] [Abstract][Full Text] [Related]
20. Determination of the acyl glucuronide metabolite of mycophenolic acid in human plasma by HPLC and Emit.
Shipkova M; Schütz E; Armstrong VW; Niedmann PD; Oellerich M; Wieland E
Clin Chem; 2000 Mar; 46(3):365-72. PubMed ID: 10702523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]